Here's Why You Should Add BrightSpring Stock to Your Portfolio Now
BTSG's specialty, infusion and home health momentum support growth, while IRA pressure and customer exits may weigh on near-term margins.
Zacks Investment Research8/12/2026Positive
BTSG
BrightSpring Health Services, Inc. Common StockNASDAQHEALTHCAREHEALTH INFORMATION SERVICES
Key Statistics
Market Cap
$11.95B
P/E Ratio
53.91
EPS
$1.12
Beta
1.88
52W High
$73.75
52W Low
$22.86
50-Day MA
$66.23
200-Day MA
$48.11
Dividend Yield
—
Profit Margin
2.55%
Forward P/E
33.90
PEG Ratio
—
About BrightSpring Health Services, Inc. Common Stock
BrightSpring Health Services, Inc. (BTSG) is a leading provider of home and community-based health services, focusing on diverse patient populations, including individuals with intellectual and developmental disabilities and those in need of rehabilitation support. The company prioritizes personalized, high-quality care, facilitated by a dedicated and skilled workforce that significantly improves patient outcomes and quality of life. With robust investments in innovative technologies and a strong commitment to value-based care, BrightSpring is well-positioned to capitalize on growth opportunities within the dynamic healthcare landscape, highlighting its potential for sustainable, long-term success.
Fundamentals
| Revenue (TTM) | $14.37B |
| Gross Profit (TTM) | $1.78B |
| EBITDA | $626.82M |
| Operating Margin | 3.37% |
| Return on Equity | 13.00% |
| Return on Assets | 4.88% |
| Revenue/Share (TTM) | $70.11 |
| Book Value | $9.94 |
| Price-to-Book | 5.96 |
| Price-to-Sales (TTM) | 0.83 |
| EV/Revenue | 0.978 |
| EV/EBITDA | 23.09 |
| Quarterly Earnings Growth (YoY) | 196.60% |
| Quarterly Revenue Growth (YoY) | 23.00% |
| Shares Outstanding | $197.86M |
| Float | $150.40M |
| % Insiders | 3.13% |
| % Institutions | 108.24% |
Historical Volatility
HV 10-Day
52.17%
HV 20-Day
87.10%
HV 30-Day
72.38%
HV 60-Day
56.25%
HV Rank
99.6%
Volatility is currently contracting
Analyst Ratings
Consensus ($78.94 target)
3
Strong Buy15
BuyLatest News
BrightSpring Health Services: A Great Business, But I'm Waiting For A Better Entry
BrightSpring Health Services (BTSG) has delivered 22% revenue CAGR over five years, with strong segment growth and a compelling integrated care platform. BTSG's Onco360 specialty pharmacy and high-margin Provider Solutions drive recurring revenue, benefiting from secular demand and insurer preference for integrated services. Valuation suggests limited upside despite strong growth prospects.
Seeking Alpha8/10/2026Positive
BrightSpring Q2 Earnings Call Highlights Growth and Raised Outlook
BTSG Health Services raises its 2026 outlook as Pharmacy and Provider growth, margin gains and lower leverage strengthen operating momentum.
Zacks Investment Research8/7/2026Positive
4 Healthcare Stocks to Watch as Defensive Demand Strengthens
Healthcare's defensive demand is strengthening in 2026. BTSG, HRMY, UNH and NVCR stand out on improving earnings outlooks and steady sector momentum.
Zacks Investment Research8/7/2026Positive
Micron & 2 Profitable Stocks Smart Investors Are Buying in August
Micron, BrightSpring Health and Custom Truck One Source combine strong profitability with earnings growth. See why they stand out in August.
Zacks Investment Research8/6/2026Positive
BrightSpring: Bullish Economics And Margin Growth
BrightSpring Health is converting its large pharmacy revenue base into faster gross profit and EBITDA growth. This is mostly due to its better margins per patient. In particular, Provider Services adds a higher-margin earnings stream. Here they benefit from acquired home health branches, which also expand BTSG's reach and longer-term growth potential.
Seeking Alpha8/6/2026Positive
3 Stocks to Buy Following Recent Broker Rating Upgrades
BJ's Restaurants, Patterson-UTI Energy and BrightSpring Health Services stand out after recent broker upgrades, backed by projected solid 2026 earnings growth.
Zacks Investment Research8/6/2026Positive
Implied Volatility Surging for BrightSpring Stock Options
Investors need to pay close attention to BTSG stock based on the movements in the options market lately.
Zacks Investment Research8/6/2026Neutral
Is BTSG a Buy as Rapid Growth Collides With Its Premium Valuation?
BrightSpring's broad-based growth and margin gains strengthen its outlook, but a premium valuation leaves little room for execution missteps.
Zacks Investment Research8/4/2026Positive
BTSG Raises 2026 Guidance as Specialty and Home Health Drive Growth
BrightSpring beat second-quarter estimates and raised its 2026 outlook as specialty, infusion and home health growth lifted margins and EBITDA.
Zacks Investment Research8/4/2026Positive
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BTSG and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 8/18/2026